Correlation Between ImmuPharma PLC and Quadrise Plc

Can any of the company-specific risk be diversified away by investing in both ImmuPharma PLC and Quadrise Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmuPharma PLC and Quadrise Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ImmuPharma PLC and Quadrise Plc, you can compare the effects of market volatilities on ImmuPharma PLC and Quadrise Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmuPharma PLC with a short position of Quadrise Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmuPharma PLC and Quadrise Plc.

Diversification Opportunities for ImmuPharma PLC and Quadrise Plc

-0.87

Correlation Coefficient

ImmuPharma PLC  Quadrise Plc

Pay attention - limited upside

The 3 months correlation between ImmuPharma and Quadrise is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding ImmuPharma PLC and Quadrise Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quadrise Plc and ImmuPharma PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmuPharma PLC are associated (or correlated) with Quadrise Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quadrise Plc has no effect on the direction of ImmuPharma PLC i.e., ImmuPharma PLC and Quadrise Plc go up and down completely randomly.

Pair Corralation between ImmuPharma PLC and Quadrise Plc

Assuming the 90 days trading horizon ImmuPharma PLC is expected to under-perform the Quadrise Plc. But the stock apears to be less risky and, when comparing its historical volatility, ImmuPharma PLC is 1.3 times less risky than Quadrise Plc. The stock trades about -0.07 of its potential returns per unit of risk. The Quadrise Plc is currently generating about 0.42 of returns per unit of risk over similar time horizon. If you would invest  308.00  in Quadrise Plc on September 29, 2024 and sell it today you would earn a total of  302.00  from holding Quadrise Plc or generate 98.05% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

ImmuPharma PLC  vs.  Quadrise Plc

ImmuPharma PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ImmuPharma PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Quadrise Plc

Risk-Adjusted Performance

20 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Quadrise Plc are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Quadrise Plc exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with ImmuPharma PLC and Quadrise Plc

The main advantage of trading using opposite ImmuPharma PLC and Quadrise Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmuPharma PLC position performs unexpectedly, Quadrise Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quadrise Plc will offset losses from the drop in Quadrise Plc's long position.

The idea behind ImmuPharma PLC and Quadrise Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.